» Articles » PMID: 20384626

Transcription Factor Sp1 Regulates Expression of Cancer-associated Molecule CD147 in Human Lung Cancer

Overview
Journal Cancer Sci
Specialty Oncology
Date 2010 Apr 14
PMID 20384626
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

CD147 is a novel cancer-associated biomarker that plays an important role in the invasion and metastasis of human lung cancer. In spite of its many known functions, little is known about CD147 transcriptional regulation. In this study, we explored the regulation of CD147 in human lung cancer tissues. Over 60% of the human lung cancer tissues expressed differential high levels of CD147. We then cloned the 5'-flanking region of the human CD147 gene and identified a critical promoter region at -108 to -42 which contained one binding site for Sp1, which was essential in up-regulating CD147 promoter activity. These results were proven by blocking Sp1 using RNAi or mithramycin A treatment and up-regulating Sp1 using transfection with eukaryotic expression vector. Consistent with the CD147 transcription activation, a high level of Sp1 expression was detected in lung cancer cell lines overexpressing CD147. Chromatin immunoprecipitation assay showed that much more Sp1 could bind to the CD147 promoter in 95-D with CD147 high expression than in SK-MES-1 with CD147 low expression. There was a significant positive correlation between CD147 expression and Sp1 expression level detected by immunohistochemistry (r = 0.831). Collectively, our results suggest that Sp1 is essential for regulating the CD147 gene expression in human lung cancer.

Citing Articles

Ovarian cancer-derived TGF-β1 induces cancer-associated adipocytes formation by activating SMAD3/TRIB3 pathway to establish pre-metastatic niche.

Gao T, Li J, Cheng T, Wang X, Wang M, Xu Z Cell Death Dis. 2024; 15(12):930.

PMID: 39719444 PMC: 11668853. DOI: 10.1038/s41419-024-07311-3.


SP1‑mediated ADAMTS5 transcription promotes IL‑1β‑induced chondrocyte injury via Wnt/β‑catenin pathway in osteoarthritis.

Hao X, Wu X Mol Med Rep. 2024; 30(2).

PMID: 38940327 PMC: 11228694. DOI: 10.3892/mmr.2024.13273.


Inference of gene regulatory networks based on directed graph convolutional networks.

Wei P, Guo Z, Gao Z, Ding Z, Cao R, Su Y Brief Bioinform. 2024; 25(4).

PMID: 38935070 PMC: 11209731. DOI: 10.1093/bib/bbae309.


Docking and molecular dynamic simulations of Mithramycin-A and Tolfenamic acid against Sp1 and survivin.

Lambring C, Fiadjoe H, Behera S, Basha R Process Biochem. 2024; 137:207-216.

PMID: 38912413 PMC: 11192519. DOI: 10.1016/j.procbio.2023.12.014.


The role of CEMIP in cancers and its transcriptional and post-transcriptional regulation.

Guo S, Guo Y, Chen Y, Cui S, Zhang C, Chen D PeerJ. 2024; 12:e16930.

PMID: 38390387 PMC: 10883155. DOI: 10.7717/peerj.16930.


References
1.
Nabeshima K, Lane W, Biswas C . Partial sequencing and characterization of the tumor cell-derived collagenase stimulatory factor. Arch Biochem Biophys. 1991; 285(1):90-6. DOI: 10.1016/0003-9861(91)90332-d. View

2.
Dynan W, Tjian R . Isolation of transcription factors that discriminate between different promoters recognized by RNA polymerase II. Cell. 1983; 32(3):669-80. DOI: 10.1016/0092-8674(83)90053-3. View

3.
Shi Q, Le X, Abbruzzese J, Peng Z, Qian C, Tang H . Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res. 2001; 61(10):4143-54. View

4.
Koga T, Suico M, Nakamura H, Taura M, Lu Z, Shuto T . Sp1-dependent regulation of Myeloid Elf-1 like factor in human epithelial cells. FEBS Lett. 2005; 579(13):2811-6. DOI: 10.1016/j.febslet.2005.04.015. View

5.
Lomberk G, Urrutia R . The family feud: turning off Sp1 by Sp1-like KLF proteins. Biochem J. 2005; 392(Pt 1):1-11. PMC: 1317658. DOI: 10.1042/BJ20051234. View